Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 24, 2017
Pharmacy Choice - News - Drug Delivery Systems - April 24, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

4/24/17 - Adamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia and OFF Time in People with Parkinson's Disease
Adamas Pharmaceuticals, Inc. today announced the presentation of two separate analyses of pooled data from the placebo-controlled Phase 3 clinical trials of ADS-5102 extended-release capsules in oral platform and poster presentation sessions at the 69 th American Academy of Neurology Annual Meeting in Boston. Adamas is excited to present this.
4/24/17 - American Regent Announces Enrollment of First Patient in Phase 3 Trial to Investigate Injectafer (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency
American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. "Iron deficiency affects up to half of all heart failure patients and is associated with impaired exercise tolerance, and mortality in patients with or without anemia, 2" said Adrian F. Hernandez,
4/24/17 - BioMarin Announces Kuvan sapropterin dihydrochloride Patent Challenge Settlement
By a News Reporter-Staff News Editor at Pharma Business Week- BioMarin Pharmaceutical Inc., announced that it has entered into a settlement agreement with Par Pharmaceutical that resolves patent litigation in the United States related to BioMarin's Kuvan 100 mg oral tablets and powder for oral solution in 100 mg packets. Under the terms of the
4/24/17 - DURECT Announces Presentation of Data from a Phase 1b Study of DUR-928 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress? 2017
DURECT Corporation, a biopharmaceutical company actively developing new therapeutics based on its Epigenetic Regulator Program and proprietary drug delivery platforms, announced that clinical data on DUR-928 were presented at The International Liver Congress TM 2017 on April 22 in Amsterdam. "DUR-928 was well tolerated in this study and plasma..
4/24/17 - Ferring Announces Exclusive Agreement with Alrise Biosystems for the Development of an Injectable, Controlled-Release Peptide
By a News Reporter-Staff News Editor at Pharma Business Week Ferring Pharmaceuticals and Alrise Biosystems announced that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise's ImSus Technology Platform for the development of an injectable, controlled-release formulation of a...
4/24/17 - Findings from University of Pittsburgh Update Knowledge of Drug Delivery Systems (Past, Present and Future of Chemodenervation with Botulinum Toxin...
Findings from University of Pittsburgh Update Knowledge of Drug Delivery Systems. According to news reporting originating in Pittsburgh, Pennsylvania, by NewsRx journalists, research stated, "We systematically reviewed preclinical and clinical studies on bladder chemodenervation with onabotulinumtoxin A to highlight current limitations and future..
4/24/17 - Findings in the Area of Drug Delivery Systems Reported from Purdue University (Development of Surface-Variable Polymeric Nanoparticles for Drug...
Findings in the Area of Drug Delivery Systems Reported from Purdue University. Funders for this research include Lilly Endowment, National Institute of Biomedical Imaging and Bioengineering, China Scholarship Council, Eli Lilly and Company. The news correspondents obtained a quote from the research from Purdue University, "Subsequent treatment with
4/24/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 18299) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Medical Imaging Drugs Advisory Committee to discuss new drug application 208-630 for 5- Aminolevulinic Acid Hydrochloride, Powder, for oral solution, submitted by NX Development Corp., an imaging agent to facilitate the real time detection and visualiza
4/24/17 - Nemaura Pharma Appoints Dr Werner Wessling as Director of Strategic Alliances
By a News Reporter-Staff News Editor at Biotech Business Week UK biotech company Nemaura Pharma is continuing its growth plans with the appointment of leading global pharmaceutical expert Dr Werner Wessling. His early career in management with Beiersdorf AG and Altana AG subsequently led to his appointment in 1987 as VP Business Development world
4/24/17 - Neurocrine Announces FDA Approval of INGREZZA TM valbenazine Capsules as the First and Only Approved Treatment for Adults with Tardive Dyskinesia TD
By a News Reporter-Staff News Editor at Mental Health Weekly Digest Neurocrine Biosciences, Inc. announced that the U.S. Food and Drug Administration has approved INGREZZATM capsules for the treatment of adults with tardive dyskinesia. INGREZZA, a novel, selective vesicular monoamine transporter 2 inhibitor, is the first and only FDA- approved pr
4/24/17 - Patent Issued for Antioxidant, Anti-Inflammatory, Anti-Radiation, Metal Chelating Compounds and Uses (USPTO 9617301)
By a News Reporter-Staff News Editor at Diabetes Week A patent by the inventors Mograbi, Josef; Atlas, Daphne; Keynan, Shoshana, filed on April 21, 2015, was published online on April 11, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9617301 is assigned to ONEDAY-BIOTECH AND PHARM
4/24/17 - Patent Issued for Particulate Materials (USPTO 9616060)
By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Kordikowski, Andreas; Walker, Stephen Ernest; York, Peter, filed on August 4, 2014, was published online on April 11, 2017. The patent's assignee for patent number 9616060 is Nektar Therapeutics. News ed
4/24/17 - Portal Instruments Receives ISO 13485:2012 Certification from NSAI
Portal Instruments, a clinical stage medical device start-up company announced today that it has received ISO 13485: 2012 Certification by the National Standards Authority of Ireland certifying body. ISO 13485: 2012, Quality Management Standard for Medical Devices is the international standard requirements for a comprehensive quality management..
4/24/17 - Precision Intratumoral Delivery of DNX-2401 with the Alcyone MEMS Cannula
HOUSTON and LOWELL, Mass., April 24, 2017/ PRNewswire/ DNAtrix, a clinical stage biotechnology company developing virus-based immunotherapies for cancer, and Alcyone Lifesciences, a leader in neural intervention systems and advanced drug delivery, will reveal clinical data demonstrating the precise administration of DNX-2401, an oncolytic adenovi
4/24/17 - Researchers at Pain Center Report New Data on Clinical Trials and Studies (Intrathecal Pump Refills, Pocket Fills, and Symptoms of Drug Overdose: A...
According to news reporting originating in Lugano, Switzerland, by NewsRx journalists, research stated, "One complication associated with the refill procedure of intrathecal drug delivery systems include a' pocket fill,' which is the inadvertent injection of the drug into the subcutaneous space surrounding the pump. For more information on this res
4/24/17 - Researchers at Texas Children's Hospital Release New Data on Clinical Trials and Studies (Incidence of infusion reactions to anti-neoplastic agents...
Our news journalists report that additional information may be obtained by contacting J. Hajjar, Texas Childrens Hosp, Baylor College of Medicine, Sect Immunol Allergy& Rheumatol, Houston, TX 77030, United States. Additional authors for this research include J. Hajjar, S. Bean, S.Q. Fu, D. Hong, D. Karp, B. Stephen, K. Hess, F. Meric-Bernstam and A
4/24/17 - Risks of diabetics fasting during Ramadan: Hypoglycemia rates w insulin pump v. injections
By a News Reporter-Staff News Editor at Diabetes Week New Rochelle, NY, A new study examining the risk of fasting during Ramadan for people with type 1 diabetes compared blood glucose control and the rates of hypoglycemia and hyperglycemia between users of insulin pump therapy versus multiple daily insulin injections. Reem Alamoudi, MD, MHSc, Ima
4/24/17 - Sanofi Receives FDA Approval of Thymoglobulin for the Prevention of Acute Kidney Transplant Rejection
Sanofi today announced that the U.S. Food and Drug Administration approved Thymoglobulin , for use in conjunction with concomitant immunosuppression in the prophylaxis, or prevention, of acute rejection in patients receiving a kidney transplant. "Thymoglobulin has been a well-established medication used in kidney transplantation for nearly 20
4/24/17 - Studies from Taishan Medical University Have Provided New Information about Drug Delivery Systems (Folic acid-functionalized drug delivery platform...
By a News Reporter-Staff News Editor at Nanotechnology Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news originating from Taian, People's Republic of China, by VerticalNews correspondents, research stated, "A folic acid- functionalized drug vehicle platform based on Pluronic 12
4/24/17 - Studies from Technical University of Denmark in the Area of Drug Delivery Systems Reported (Loading of Drug-Polymer Matrices in Microreservoirs for...
Studies from Technical University of Denmark in the Area of Drug Delivery Systems Reported. According to news reporting originating in Lyngby, Denmark, by VerticalNews journalists, research stated, "For major advances in microfabricated drug delivery systems, fabrication methods with high throughput using biocompatible polymers are required.
4/24/17 - Study Results from T. Pelras and Colleagues Broaden Understanding of Drug Delivery Systems (A 'grafting from' approach to polymer nanorods for...
By a News Reporter-Staff News Editor at Nanotechnology Weekly Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. For more information on this research see: A' grafting from' approach to polymer nanorods for pH-triggered intracellular drug delivery. Polymer, 2017; 112: 244-251. Polymer can be contacted a
4/24/17 - Theravance Biopharma Reports Positive Clinical Response Rates for Patients in TOUR? Observational Patient Registry in Several Presentations at ECCMID 2017
Theravance Biopharma, Inc. today announced that new preliminary data from the ongoing Telavancin Observational Use Registry study are the focus of three poster presentations at the 27th European Congress of Clinical Microbiology and Infectious Diseases. The 27 th ECCMID is being held in Vienna, Austria, April 22-25, 2017. The TOUR findings being
4/24/17 - U.S. FDA Approves New Indications for Harvoni and Sovaldi in Pediatric Patients 12 Years and Older with Chronic Hepatitis C Infection
By a News Reporter-Staff News Editor at Clinical Trials Week Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration has approved supplemental indications for Harvoni tablets and Sovaldi tablets for the treatment of chronic hepatitis C virus infection in adolescents without cirrhosis or with compensated cirrhosis, 12 year
4/23/17 - Data on Clinical Trials and Studies Described by Researchers at Fred Hutchinson Cancer Research Center [Midyear Commentary on Trends in Drug Delivery...
Data on Clinical Trials and Studies Described by Researchers at Fred Hutchinson Cancer Research Center. According to news reporting originating in Seattle, Washington, by NewsRx editors, the research stated, "Before the 2009 Biologics Price Competition and Innovation Act that enabled the U.S. Federal Drug Administration to create the 351 Biologic L
4/23/17 - Dr. Reddy's Lab launches Progesterone capsules in the U.S. market [India Infoline News Service]
Reddy s Laboratories Ltd., announced on April 21, 2017 that it has launched Progesterone Capsules, 100 mg and 200 mg in U.S. market Dr. Reddy s Laboratories Ltd. announced on April 21, 2017, that it has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium* capsules in the United States mark
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415